Zobrazeno 1 - 10
of 565
pro vyhledávání: '"Hatem, E"'
Autor:
Hatem E. Gaffer, S. A. Mahmoud, M. S. El-Sedik, Tarek Aysha, Mohamed H. Abdel-Rhman, Ehab Abdel-latif
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-17 (2024)
Abstract In this study, we synthesized new series of 5-oxo-2-phenyl-4-(arylsulfamoyl)sulphenyl) hydrazono)-4,5-dihydro-1H-pyrrole-3-carboxylate hybrids 4a-f with the goal of overcoming sulfonamide resistance and identifying novel therapeutic candidat
Externí odkaz:
https://doaj.org/article/62f11ae8d9ea4200a05f8e42fd5f0c61
Autor:
Gaffer, Hatem E., Khattab, Tawfik A., Abdel-latif, Ehab, Shahin, Hazem, Abdel-Rhman, Mohamed H.
Publikováno v:
In Journal of Molecular Structure 5 October 2024 1313
Autor:
Gaffer, Hatem E.1 (AUTHOR) hatemgaafar197@gmail.com, Mahmoud, S. A.1 (AUTHOR), El-Sedik, M. S.1 (AUTHOR), Aysha, Tarek1 (AUTHOR), Abdel-Rhman, Mohamed H.2 (AUTHOR), Abdel-latif, Ehab2 (AUTHOR)
Publikováno v:
Scientific Reports. 5/14/2024, Vol. 14 Issue 1, p1-17. 17p.
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-17 (2023)
Abstract 3-Amino-4,6-dimethylpyrazolopyridine was applied as a precursor for the synthesis of some new pyridopyrazolo-triazine and pyridopyrazolo-triazole derivatives through diazotization, followed by coupling with many 2-cyanoacetamide compounds, e
Externí odkaz:
https://doaj.org/article/5b5137706c474da29bd7ed53d5347ab0
Publikováno v:
Biomedicines, Vol 11, Iss 12, p 3304 (2023)
Alzheimer’s disease is a genetically complex disorder, and microarray technology provides valuable insights into it. However, the high dimensionality of microarray datasets and small sample sizes pose challenges. Gene selection techniques have emer
Externí odkaz:
https://doaj.org/article/9ee28093773140deb11638b52e15167f
Autor:
Isaac Yi Kim, Antonina Mitrofanova, Sukanya Panja, Joshua Sterling, Arnav Srivastava, Juliana Kim, Sinae Kim, Eric A. Singer, Thomas L. Jang, Saum Ghodoussipour, Biren Saraiya, Tina Mayer, Hatem E. Sabaawy, Bertram Yuh, Seok Soo Byun, Wun-Jae Kim, Shigeo Horie
Publikováno v:
Prostate International, Vol 10, Iss 2, Pp 75-79 (2022)
Purpose: Approximately 7% of patients with newly diagnosed prostate cancer (PCa) in the US will have have metastatic disease. The dogma that there is no role for surgery in this population has been questioned recently. Here we report long-term outcom
Externí odkaz:
https://doaj.org/article/2f501ee924ff43f5a17b5dc4d22e57f9
Autor:
Kim, Isaac Yi, Mitrofanova, Antonina, Panja, Sukanya, Sterling, Joshua, Srivastava, Arnav, Kim, Juliana, Kim, Sinae, Singer, Eric A., Jang, Thomas L., Ghodoussipour, Saum, Saraiya, Biren, Mayer, Tina, Sabaawy, Hatem E., Yuh, Bertram, Byun, Seok Soo, Kim, Wun-Jae, Horie, Shigeo
Publikováno v:
In Prostate International June 2022 10(2):75-79
Publikováno v:
In Journal of Molecular Structure 5 May 2022 1255
Publikováno v:
ChemistrySelect; Oct2024, Vol. 9 Issue 37, p1-14, 14p
Autor:
Sahithi Pamarthy, Hatem E. Sabaawy
Publikováno v:
Molecular Cancer, Vol 20, Iss 1, Pp 1-13 (2021)
Abstract With advances in the discovery of the clinical and molecular landscapes of prostate cancer (PCa), implementation of precision medicine-guided therapeutic testing in the clinic has become a priority. Patient derived organoids (PDOs) are three
Externí odkaz:
https://doaj.org/article/f9c2766482634be1b94dbe3a2f1b40f7